VALIDATION OF A DEVELOPED ANALYTICAL METHOD FOR DETERMINATION OF NATEGLINIDE AND METFORMIN HCL IN PURE AND PHARMACEUTICAL DOSAGE FORM BY REVERSED-PHASE HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY AND ITS DEGRADATION STUDIES

  • K.MD ISMAIL Department of Pharmaceutical Analysis, Nizam Institute of Pharmacy, Deshmukhi Village, Nalgonda, Telangana, India.
  • A LAKSHMANA RAO Department of Pharmaceutical Analysis, V.V. Institute of Pharmaceutical Sciences, Gudlavalleru, Krishna, Andhra Pradesh, India.

Abstract

Objective: The objective of the study was to develop a versatile analytical method and validate according to International Council for Harmonization guidelines for simultaneous estimation of nateglinide and metformin HCl by reversed-phase high-performance liquid chromatography (RP-HPLC) in active pharmaceutical ingredient and in tablet dosage form.


Methods: Analytes, metformin and nateglinide, are separated and eluted from stationary phase luna phenyl hexyl column (150 mm ×4.6 mm, 3.5 μm) (micrometer) using polar mobile phase composed of acetonitrile:1% orthophosphoric acid 30:70 v/v, with flow rate of 1 ml/min for 8 min at ambient column temperature, at 221 nm (nanometer) detection. Acid, base, peroxide, thermal, and photolytic-induced degradation studies were performed on nateglinide and metformin.


Results: Through isocratic flow, both metformin and nateglinide are detected at retention times of 2.79 min and 5.13 min, respectively, at 221 nm. The linearity and range of analytical method for nateglinide and metformin were 0.61–9.15 μg/ml and 7.5–75.15 μg/ml, respectively. The R2 value for nateglinide was 0.9998 and for metformin HCl was 0.9991. The limit of detection and limit of quantification for nateglinide were 0.21 μg/ml and 0.63 μg/ml and for metformin were 4.8 μg/ml and 14.6 μg/ml, respectively. The % relative standard deviation for method precision was found to be 0.22% and 0.64% for both nateglinide and metformin, respectively. The mean %recovery for nateglinide and metformin was 99.88% and 99.21%, respectively. The %thermal degradation was identified as 17.7% and 17.5% for nateglinide and metformin, respectively.


Conclusion: The developed chromatographic (RP-HPLC) method was selective, specific, economic, precise, and accurate. Hence, it can be one of the preferred analytical methods of choice for the estimation of nateglinide and metformin by RP-HPLC in pure and in tablet dosage form.

Keywords: Nateglinide, Metformin, Reversed-phase high-performance liquid chromatography, Isocratic, Acetonitrile

References

1. Hirschberg Y, Karara AH, Pietri AO, McLeod JF. Improved control of mealtime glucose excursions with coadministration of nateglinide and metformin. Diabetes Care 2000;23:349-53.
2. Horton ES, Clinkingbeard C, Gatlin M, Foley J, Mallows S, Shen S. Nateglinide alone and in combination with metformin improves glycemic control by reducing mealtime glucose levels in Type 2 diabetes. Diabetes Care 2000;23:1660-5.
3. Geetha P, Sundharam PS. Drug utilization evaluation of antidiabetic drugs among Type 2 diabetes patients of Tamil Nadu. Asian J Pharm Clin Res 2017;10:202-5.
4. Muhas C, Naseef PP. A review article-gestational diabetes mellitus. Int J Curr Pharm Res 2017;9:1-5.
5. Natasya A, Andrajati R, Sauriasari R. Cross-sectional study of association between glycemic control and quality of life among diabetic patients. Int J App Pharm 2018;10:92-6.
6. Dhodi JB, Mestry SN, Juvekar AR. Diabetic nephropathy-genesis, prevention, and treatment. Int J Pharm Pharm Sci 2014;6:42-7.
7. Thomas A, Patil S, Nanda R, Kothapalli L, Deshpande A. Stability-indicating RP-HPLC method for determination of metformin hydrochloride and nateglinide in bulk and tablet formulations. Curr Pharm Anal 2012;8:381-8.
8. Chengalva P, Parameswari SA, Aruna G. Development and validation of RP-HPLC method for metformin hydrochloride and nateglinide in bulk and combined dosage form. Int J Pharm Pharm Sci 2016;8:267-71.
9. El-Zaher AA, Elkady EF, Elwy HM, Saleh MA. A new rapid and economic liquid chromatographic method for simultaneous determination of meglitinides with metformin: Application in the presence of metformin and repaglinide impurities and related compounds. J Iran Chem Soc 2018;15:61-74.
10. Haranadha R, Chunduri B, Dannana GS. Development and validation of LC-MS/MS method for simultaneous quantification of metformin HCL and nateglinide in human plasma and its application to a pharmacokinetic study. World J Pharm Pharm Sci 2016;5:651-67.
11. Ramanjireddy T, Duraiswamy D, Kothapalli C. Method development and validation of Metformin and repaglinide in rabbit plasma by RP-HPLC. Fabad J Pharm Sci 2012;35:69-75.
12. Patel JR, Suhagia BN, Patel BH. Simultaneous spectrophotometric estimation of metformin and repaglinide in a synthetic mixture. Indian J Pharm Sci 2007;69:844-6.
13. Thomas AB, Patil SD, Kothapalli LP, Nanda RK, Bhosle SS, Deshpande AD. Estimation of nateglinide and metformin hydrochloride in tablet dosage form by spectrophotometric methods. J Pharm Res 2011;10:102-5.
14. Soni LK, Narsinghani T, Jain M. Development and validation of RP-HPLC method for simultaneous estimation of metformin hydrochloride and repaglinide in tablet dosage form. J Liq Chromatogr Relat Technol 2012;35:385-92.
15. Aslan SS, Yilmaz B. Derivative spectrophotometric and isocratic high performance liquid chromatographic methods for simultaneous determination of repaglinide and metformin hydrochloride in pharmaceutical preparations. Am J Anal Chem 2017;8:541-52.
16. Fouad M, Rashed NS. Development and validation of chromatographic and spectroscopic methods for estimation of repaglinide and metformin HCL in combined dosage form. J Glob Trends Pharm Sci J 2014;5:1844-8.
17. Sheth KB, Sagar GV. Development and validation of RP-HPLC method for simultaneous estimation of metformin hydrochloride and mitiglinide calcium dihydrate in combined dosage form. Pharm Sci Monit 2012;3:2681-93.
18. Elkady EF, El-Zaher AA, Elwy HH, Saleh MA. Validated liquid chromatographic method for simultaneous determination of Metformin, pioglitazone, sitagliptin, repaglinide, glibenclamide and gliclazide-application for counterfeit drug analysis. J Anal Bioanal Tech 2015;S13:1-8.
19. El-Wasseef DR. Simultaneous determination of metformin, nateglinide and gliclazide in pharmaceutical preparations using micellar liquid chromatography. Int J Biomed Sci 2012;8:144-51.
20. Thomas AB, Patil SD, Nanda RK, Kothapalli LP, Bhosle SS, Deshpande AD. Stability-indicating HPTLC method for simultaneous determination of nateglinide and metformin hydrochloride in pharmaceutical dosage form. Saudi Pharm J 2011;19:221-31.
21. Ahir KB, Patelia EM, Shah A. Simultaneous estimation of metformin hydrochloride and repaglinide in pharmaceutical formulation by HPTLC-densitometry method. J Chromatogr Sep Tech 2013;4:1-5.
22. Skoog DA, West DM, Holler FJ, Crounch S. Fundamentals of Analytical Chemistry. 8th ed. London: Thomson Asia Pvt Ltd.; 2004. p. 160-7, 971-95.
23. Ahuja S, Dong M, editors. Handbook of Pharmaceutical Analysis by HPLC. Vol. 6. Amsterdam, Boston: Elsevier Academic Press; 2005. p. 19-44, 47-69, 197-210.
24. Snyder L, Kirkland JJ, Glajch JL. Practical HPLC Method Development. 2nd ed. Hoboken, New Jersey: John Wiley and Sons Inc.; 1997. p. 1-542.
25. International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use. Validation of Analytical Procedures- Text and Methodology; ICH Q2 (R1); 2005.
Statistics
76 Views | 50 Downloads
Citations
How to Cite
ISMAIL, K., and A. L. RAO. “VALIDATION OF A DEVELOPED ANALYTICAL METHOD FOR DETERMINATION OF NATEGLINIDE AND METFORMIN HCL IN PURE AND PHARMACEUTICAL DOSAGE FORM BY REVERSED-PHASE HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY AND ITS DEGRADATION STUDIES”. Asian Journal of Pharmaceutical and Clinical Research, Vol. 14, no. 1, Jan. 2021, pp. 196-02, doi:10.22159/ajpcr.2021.v14i1.39530.
Section
Original Article(s)